1. Immune Cell Density as a Predictive Index for Response to Treatment and Outcome of High Risk MDS Treated with 5-Azacytidine. (April 2017) Authors: Tsakiraki, Z.; Papageorgiou, S.; Spathis, A.; Bouchla, A.; Bazani, E.; Glezou, E.; Karakitsos, P.; Panayiotides, I.; Pappa, V.; Foukas, P. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1917: PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF ELEMENTS OF THE ADAPTIVE IMMUNITY IN THE MICROENVIRONMENT OF MYELODYSPLASTIC SYNDROMES TREATED WITH 5-AZACITIDINE. (23rd June 2022) Authors: Tsakiraki, Z.; Papageorgiou, S.; Spathis, A.; Pouliakis, A.; Bouchla, A.; Thomopoulos, T.; Panayiotides, I. G.; Pappa, V.; Foukas, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗